Prostate News Archive
10-Apr-2009
Drug Shows Activity In Men With Advanced Prostate Cancer (Medical News Today)
A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels a marker for tumor growth in men with advanced prostate cancer for whom traditional treatment options have failed. The study, led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC), is published in Science Express, the online version of the journal Science. Medivation Prostate Cancer Drug Blocks Tumor Protein (Update2) (Bloomberg)
April 7 (Bloomberg) -- An experimental prostate cancer drug from Medivation Inc. cut levels of a protein linked to the malignancy in patients with tumors that had grown resistant to conventional treatments, scientists said. Gene fusion discovery may lead to improved prostate cancer test (PhysOrg)
A newly discovered gene fusion is highly expressed in a subset of prostate cancers, according to a study by researchers at Weill Cornell Medical College. The findings, reported in the April 1 issue of Cancer Research, may lead to more accurate tests for prostate cancer. The gene fusion biomarker is also a different type of fusion than researchers have found in cancer previously and may represent ... Drug drops PSA in men with prostate cancer (UPI)
NEW YORK, April 9 (UPI) -- An experimental drug lowers prostate specific antigen levels -- a marker for tumor growth -- in men with advanced prostate cancer, U.S. researchers say. Daily pill that could halt prostate cancer 'ready in three years' (Daily Mail)
Daily pill that could halt prostate cancer 'ready in three years'
Back to Prostate News Archive
